Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elliot S Vesell

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Pharmacology|September 30, 2006
Pharmacology and statistics: recommendations to strengthen a productive partnershipReynold Spector, Elliot S Vesell
Pharmacology|April 9, 2002
A rational approach to the selection of useful drugs for clinical practiceReynold Spector, Elliot S Vesell
Pharmacology|May 9, 2006
The heart of drug discovery and development: rational target selectionReynold Spector, Elliot S Vesell
Journal of Clinical Pharmacology|September 5, 2002
Which studies of therapy merit credence? Vitamin E and estrogen therapy as cautionary examplesReynold Spector, Elliot S Vesell
Pharmacology|February 2, 2006
The power of pharmacological sciences: the example of proton pump inhibitorsReynold Spector, Elliot S Vesell
Trends in Pharmacological Sciences|September 29, 2006
Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomicsDaniel W Nebert, Elliot S Vesell
The Journal of Clinical Investigation|October 7, 2004
From progress to regression: biomedical research fundingH George Mandel, Elliot S Vesell
European Journal of Pharmacology|October 7, 2004
Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie aheadDaniel W Nebert, Elliot S Vesell
Drug Metabolism Reviews|May 9, 2008
From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directionsDaniel W Nebert, Ge Zhang, Elliot S Vesell
Annual Review of Pharmacology and Toxicology|January 9, 2013
Genetic risk prediction: individualized variability in susceptibility to toxicantsDaniel W Nebert, Ge Zhang, Elliot S Vesell
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Pharmacology|September 30, 2006
Pharmacology and statistics: recommendations to strengthen a productive partnershipReynold Spector, Elliot S Vesell
Pharmacology|April 9, 2002
A rational approach to the selection of useful drugs for clinical practiceReynold Spector, Elliot S Vesell
Pharmacology|May 9, 2006
The heart of drug discovery and development: rational target selectionReynold Spector, Elliot S Vesell
Journal of Clinical Pharmacology|September 5, 2002
Which studies of therapy merit credence? Vitamin E and estrogen therapy as cautionary examplesReynold Spector, Elliot S Vesell
Pharmacology|February 2, 2006
The power of pharmacological sciences: the example of proton pump inhibitorsReynold Spector, Elliot S Vesell
Trends in Pharmacological Sciences|September 29, 2006
Can personalized drug therapy be achieved? A closer look at pharmaco-metabonomicsDaniel W Nebert, Elliot S Vesell
The Journal of Clinical Investigation|October 7, 2004
From progress to regression: biomedical research fundingH George Mandel, Elliot S Vesell
European Journal of Pharmacology|October 7, 2004
Advances in pharmacogenomics and individualized drug therapy: exciting challenges that lie aheadDaniel W Nebert, Elliot S Vesell
Drug Metabolism Reviews|May 9, 2008
From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directionsDaniel W Nebert, Ge Zhang, Elliot S Vesell
Annual Review of Pharmacology and Toxicology|January 9, 2013
Genetic risk prediction: individualized variability in susceptibility to toxicantsDaniel W Nebert, Ge Zhang, Elliot S Vesell
Pageof 2